SART3/TIP110 Antibody

SART3 (squamous cell carcinoma antigen recognized by T cells 3) was identified as an antigenic peptide expressed in esophageal cancer cells that is recognized by cytotoxic T lymphocytes. Originally, in a search for a U6 small nuclear RNA capping enzyme, SART3 was identified as a 110kDa nuclear RNA-binding protein. Later, by database searching, SART 3 was determined to also be the human ortholog of the yeast Prp24 snRNP recycling factor that functions in the reassembly of the U4/U6 snRNP during the recycling phase of the splicesome cycle. Recently, SART3-derived peptides have been investigated as candidates for peptide-based immunotherapy in prostate cancer patients due to their ability to induce cytotoxic T lymphocyte activity against prostate cancer cells.
    Product Specifications
    Catalog # Size Price
    SART3/TIP110 AntibodyReactivity: Human
    Applications: WB, IP, IHC-P, IF
    Immunogen: Between 600 and 650
    A301-521A100 µl (0.2 mg/ml) $339Add to Cart
    A301-521A-M100 µl (10 blots) $229Add to Cart
    A301-521A-T20 µl (2 blots) $50Add to Cart
    SART3/TIP110 AntibodyReactivity: Human
    Applications: WB, IP, IHC-P, IF
    Immunogen: Between 913 and 963
    A301-522A100 µl (0.2 mg/ml) $339Add to Cart
    A301-522A-M100 µl (10 blots) $229Add to Cart
    A301-522A-T20 µl (2 blots) $50Add to Cart
    SART3/TIP110 IHC AntibodyApplications: IHC-P, IF
    Reactivity: Human
    Immunogen: Between 600 and 650
    IHC-00294100 µl (50 slides) $360Add to Cart
    Applications: WB, IP, IHC-P, IF
    Reactivity: Human
    Includes: 1 each of A301-521A and A301-522A
    A310-533A1 Pack $472Add to Cart

    Please note that Cookies and JavaScript are required for you to view this website.

    Check if you have Cookies and JavaScript enabled in your browser